Patents by Inventor Stéphane Mutti

Stéphane Mutti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7396934
    Abstract: The invention relates to a novel preparation of 3-fluoroquinolines of formula (I) in which R1, R2, R3 and R4 represent: a) a fluorine; b) an alkyl optionally substituted with one to three fluorines, with OR5 in which R5 is an alkyl, a hydrogen or a hydroxyl-protecting group, or with NR?R? in which R? and R? represent an alkyl, a hydrogen or an amino-protecting group; c) OR6 in which R6 represents a hydrogen, a phenol-protecting group or an alkyl, optionally substituted with a fluorine, with OR5 or with NR?R? as defined above; d) NR?1R?1 in which R?1 and R?1 have the values of R? et R? or represent an alkyl substituted with a fluorine, with OR5 or NR?R? as defined above; e) CO2Ra, in which Ra represents hydrogen, alkyl or a carboxyl-protecting group, and also novel intermediate compounds. The quinolines of formula (I) are intermediates useful in the preparation of compounds having antibacterial activity, described in particular in applications WO 02/40474 or WO 02/72572.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: July 8, 2008
    Inventors: Youssef El-Ahmad, Jean-Pierre Leconte, Joël Malpart, Serge Mignani, Stéphane Mutti, Michel Tabart
  • Patent number: 6815547
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: November 9, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacque, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié
  • Patent number: 6759555
    Abstract: The present invention provides novel processes for the preparation of combretastatins or stilbene compounds of formulae (I) and (III) wherein A is NH2 or and PG is a protecting group.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: July 6, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Stéphane Mutti, Michel Lavigne, Irina Malejonock, Jean-Paul Casimir
  • Patent number: 6602884
    Abstract: Quinolylpropylpiperidine derivatives of general formula (I) are described, and are useful as antimicrobial agents. Their preparation is also described.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Eric Bacqué, Serge Mignani, Jean-Luc Malleron, Michel Tabart, Michel Evers, Fabrice Viviani, Youssef El Ahmad, Stéphane Mutti, Christophe Daubié